type 1 diabetes and glp-1 vs. GLP-1 + GIP: What's the Difference for your Metabolism? Ask an Endo with IG:YoureJustMyType1

Future Directions and Challenges 1

Reveals of new candidate active components in Hemerocallis Radix and its anti-depression action of mechanism based on network pharmacology approach

One drug pulls one lever

BPC-157 , ,

Over the course of the next six months, PrecisionLife will reproduce, refine, and validate their findings using additional datasets provided by Ovation, including studies to confirm the predicted response to GLP-1 drugs including semaglutide and tirzepatide in a real-world context

patients receiving ADMs saw noticeable spikes in the rate of discontinuation due to medication availability in January 2023 (5.3%) and June 2024 (4.8%), while patients receiving AOMs experienced higher rates of discontinuation due to medication availability throughout 2023 and into early 2024